Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Anti-HBV nucleosides from Chong Kun Dang

June 23, 1997

Axcan to distribute Ursofalk in Canada

June 20, 1997

Combination therapy approved by FDA for H. pylori eradication

June 20, 1997

Synsorb Biotech receives U.S. patent coverage for treatment of diarrhea

June 18, 1997

Interferon/ribavirin compared to interferon and ribavirin monotherapy in chronic hepatitis C

June 17, 1997

Potent and selective beta3-adrenoceptor agonists claimed by Tokyo Tanabe

June 17, 1997

Vertex and Lilly join forces in hepatitis C drug development

June 16, 1997

SKB describes development of 5-HT4 antagonists for IBS

June 16, 1997

Abbott describes SAR leading to prokinetic motilides

June 16, 1997

Schering-Plough and Corvas sign hepatitis research collaboration

June 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...